<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>381</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15099751</PubmedId>
            <Abstract>One hundred and fifty-one human sera from patients exposed to rubella virus (RV) and shown to be negative for IgM antibodies were tested for total RV-IgG, hemagglutination inhibition (HAI) and for virus neutralizing (VN) antibodies using a peptide enzyme-linked immunosorbent assay (ELISA) based on BCH-178, a peptide representing one of several known neutralizing epitopes on RV hemagglutinin (E1). The data showed that, among 39 and 51 sera with HAI and RV-IgG titres of 1/128 and &gt;150 IU/ml, respectively, neutralizing antibody readings using the BCH-178 ELISA were above cut-off values. However, 13% of HAI positive sera (titre &gt; or =1/16) and 16% of RV-IgG ELISA positive sera (&gt; or =20 IU/ml) were below the cut-off value of the BCH-178 ELISA. This may explain why several cases of congenital rubella syndrome (CRS) have been observed in spite of positive titres. We suggest that a diagnosis of sufficient immunity against RV infection or reinfection may be safer if an additional test detecting antibodies against VN RV epitopes is positive as well.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>1-11</ArticlePages>
            <ArticleTitle>A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Giessauf</LastName>
                    <ForeName>Andreas</ForeName>
                </Author>
                <Author>
                    <LastName>Letschka</LastName>
                    <ForeName>Thomas</ForeName>
                </Author>
                <Author>
                    <LastName>Walder</LastName>
                    <ForeName>Gernot</ForeName>
                </Author>
                <Author>
                    <LastName>Dierich</LastName>
                    <ForeName>Manfred P</ForeName>
                </Author>
                <Author>
                    <LastName>Würzner</LastName>
                    <ForeName>Reinhard</ForeName>
                </Author>
            </Authors>
            <Affiliations>Institut für Hygiene und Sozialmedizin, Leopold-Franzens-University Innsbruck, Fritz Pregl-Str. 3, A-6020 Innsbruck, Austria. andreas.giessauf@uni-graz.at</Affiliations>
            <ArticleChemicalList>Antibodies, Viral;Epitopes, B-Lymphocyte;Peptides;Viral Envelope Proteins;rubella antibodies;E1 envelope protein, Rubella virus</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Viral(blood); Enzyme-Linked Immunosorbent Assay(methods); Epitopes, B-Lymphocyte(chemistry; immunology); Female; Hemagglutination Inhibition Tests; Humans; Male; Molecular Sequence Data; Peptides(immunology); Reproducibility of Results; Rubella virus(immunology); Sensitivity and Specificity; Viral Envelope Proteins(chemistry; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>287</Volume>
                <Issue>1-2</Issue>
                <Title>Journal of immunological methods</Title>
                <Issn>0022-1759</Issn>
                <MedlineTa>J Immunol Methods</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>BCH-178</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NQQSRWGLGSPNCHGPDWASPVCQRHS</LinearSequence>
                        <StartingPosition>795</StartingPosition>
                        <EndingPosition>821</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>ABD64214.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11041</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>45612</EpitopeId>
                <ReferenceStartingPosition>213</ReferenceStartingPosition>
                <ReferenceEndingPosition>239</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <BCellId>566</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:8781</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11041</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Rubella virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Sera were taken from rubella virus IgG positive and IgM negative individuals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>132</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>109</NumberOfSubjectsResponded>
                            <ResponseFrequency>82.6</ResponseFrequency>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>BCH-178</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NQQSRWGLGSPNCHGPDWASPVCQRHS</LinearSequence>
                                        <StartingPosition>795</StartingPosition>
                                        <EndingPosition>821</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>ABD64214.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11041</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

